Preclinical atherosclerosis and metabolic syndrome increase cardio- and cerebrovascular events rate: A 20-year follow up

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Novo, Salvatore ^a,b   Peritore, Angelica ^a,b   Trovato, Rosaria L ^b   Guarneri, Francesco P ^a,b   Di Lisi, Daniela ^b   Muratori, Ida ^a,b   Novo, Giuseppina ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Asymptomatic carotid plaque; Cardiac event; Cerebrovascular events; Intima media thickness; Metabolic syndrome; Preclinical atherosclerosis

Indexed keywords

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; AORTIC ANEURYSM, THORACIC; ASYMPTOMATIC DISEASES; BODY MASS INDEX; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CEREBROVASCULAR DISORDERS; DYSLIPIDEMIAS; ENDARTERECTOMY; FEMALE; HUMANS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; OBESITY; PLAQUE, ATHEROSCLEROTIC; RISK ASSESSMENT; RISK FACTORS; SMOKING; STROKE; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84886013625     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-155     Document Type: Article

References (47)

1. Dahl-Jørgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?. Diabetologia 2005, 48:1445-1453.
2. Panayiotou AG, Griffin M, Kouis P, Tyllis T, Georgiou N, Bond D, Nicolaides AN. Association between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: a population study. Diabetol Metab Syndr 2013, 5(1):44.
3. Koskinen J, Kahonen M, Viikari JSM. Conventional CV risk factors and MetS in predicting carotid intima-media thickness progression in young adults. The CV risk in young Finns study. Circulation 2009, 120:229-236.
4. Heiss G, Sharrett AR, Barnes R. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991, 134:250-256.
5. Lande MB, Carson NL, Roy J. Effects of childhood primary hypertension on carotid intima media thickness. A matched controlled study. Hypertension 2006, 48:40-44.
6. Puato M, Palatini P, Zanardo M. Increase in carotid intima-media thickness in grade I hypertensive subjects. White-coat versus sustained hypertension. Hypertension 2008, 51:1300-1305.
7. Milio G, Corrado E, Novo S. Asymptomatic carotid lesions and aging: Role of hypertension and other traditional and emerging risk factors. Arch Med Res 2006, 37:342-347.
8. Brohall G, Oden A, Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med 2006, 23:609-616.
9. Linnebank M, Moskau S, Farmand S. Homocysteine and carotid intima-media thickness in a German population: lack of clinical relevance. Stroke 2006, 37:2840-2842.
10. Thakore AH, Guo CY, Larson MG. Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol 2007, 99:1598-1602.
11. Tavil Y, Kaya MG, Oktar SO. Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis 2008, 197:159-163.
12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
13. Novo S, Balbarini A, Belch JJ. The metabolic syndrome: definition, diagnosis and management. Int Angiol 2008, 27:220-231.
14. Novo G, Corrado E, Muratori I, Novo S. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome. Int Angiol 2007, 26:312-317.
15. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among U.S. adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
16. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
17. Kawamoto R, Tomita H, Inoue A, Ohtsuka N, Kamitani A. Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men. J Atheroscler Thromb 2007, 14:36-43.
18. NcNeill AM, Rosamond WD, Girman CJ. Prevalence of coronary heart disease and carotid thickening in patients with metabolic syndrome (the ARIC study). Am J Cardiol 2004, 94:1249-1254.
19. Scuteri A, Najjar SS, Muller DC, Andres Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 2004, 43:1388-1395. Andres.
20. Tzou WS, Douglas PS, Srinivasan SR. Increased preclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa heart study. J Am Coll Cardiol 2005, 46:457-463.
21. Sipila K, Moilanem L, Nieminen T. Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis 2009, 204:276-281.
22. Novo S, Peritore A, Guarneri FP. Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study. Atherosclerosis 2012, 223:468-472.
23. Alberti KG, Eckel RH, Grundy SM. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
24. Corrado E, Rizzo M, Novo S. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke 2006, 37:482-486.
25. Salonen R, Haapanen A, Salonen JT. Measurement of intima media thickness of common carotid arteries with high resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Biol 1991, 17:225-230.
26. Bots ML, Grobbee DE. Intima Media Thickness as a Surrogate Marker for Generalized Atherosclerosis. Cardiovasc Drugs Therapy 2002, 16:341-351.
27. Crouse JR, Goldbourt U, Evans G. Risk Factors and Segment-Specific Carotid Arterial Enlargement in the Atherosclerosis Risk in Communities (ARIC) Cohort. Stroke 1996, 27:69-75.
28. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997, 96:1432-1437.
29. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SKJ. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. Ann Internal Med 1999, 340:14-22.
30. Urbina EM, Srinivasan SR, Tang R, Bond MG, Kieltyka L, Berenson GS, Study BH. Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (the Bogalusa heart study). Am J Cardiol 2002, 90:953-958.
31. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993, 87:156-165.
32. Rathsman B, Rosfors S, Sjöholm A, Nyström T. Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes. Cardiovasc Diabetol 2012, 11:145.
33. Sousa MA, Guimarães IC, Daltro C, Guimarães AC. Association between birth weight and cardiovascular risk factors in adolescents. Arq Bras Cardiol 2013, 101:9-17.
34. Freire CM, Barbosa FB, de Almeida MC, Miranda PA, Barbosa MM, Nogueira AI, Guimarães MM, Nunes Mdo C, Ribeiro-Oliveira A. Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome - a case control study. Cardiovasc Diabetol 2012, 11:59.
35. Johnsen SH, Mathiesen EB, Joakimsen O. Carotid atherosclerosis is a stronger predictor of myocardial infarction in study women than in Men: a 6-year follow-up study of 6226 persons: the tromso. Stroke 2007, 38:2873-2880.
36. Rizzo M, Corrado E, Novo S. Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis 2008, 200:389-395.
37. Novo S, Visconti CL, Amoroso GR. Asymptomatic carotid lesions add to CV risk prediction. Eur J Cardiovasc Prev Rehabil 2010, 17:514-518.
38. Birdsill AC, Carlsson CM, Willette AA, Okonkwo OC, Johnson SC, Xu G, Oh JM, Gallagher CL, Koscik RL, Jonaitis EM, Hermann BP, Larue A, Rowley HA, Asthana S, Sager MA, Bendlin BB. Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity (Silver Spring) 2013, 21:1313-1320.
39. Baldassare D, Hamsten A, Veglia F. IMPROVE Study Group. Measurements of Carotid Intima- Media thickness and of Interadventitia Common Carotid Diameter Improve Prediction of Cardiovascular Events: Results of the IMPROVE (Carotid Intima Media Thickness and IMT progression as Predictors of vascular events in a high risk European Population) Study. J Am Coll Cardiol 2012, 60:1489-1499.
40. Nambi V, Chambless L, Folsom AR. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2010, 13(55):1600-1607.
41. Sehestedt T, Jeppesen J, Hansen TW. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 2010, 31:883-891.
42. Mookadam F, Moustafa SE, Lester SJ, Warsame T. Subclinical atherosclerosis: evolving role of carotid intima-media thickness. Prev Cardiol 2010, 13:186-197.
43. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol 2012, 19:585-667.
44. Herder M, Arntzen KA, Johnsen SH, Mathiesen EB. The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study. Cardiovasc Diabetol 2012, 11:77.
45. Novo S, Carità P, Corrado E. Preclinical carotid atherosclerosis enhances the global cardiovascular risk and increases the rate of cerebro- and cardiovascular events in a five-year follow-up. Atherosclerosis 2010, 211:287-290.
46. Laaksonen DE, Lakka HM, Salonen JT, Niskanen LK, Rauramaa R, Lakka TA. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 2002, 25:1612-1618.
47. Shah PK. Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we?. J Am Coll Cardiol 2010, 56:98-105.